Navigation Links
Anti Atherosclerosis Therapies Linked to Leukemia

Scientists studying inflammation and atherosclerosis have recently seen a convergence of their respective fields. Another recent discovery made during the study// of anti atherosclerosis therapies was a tendancy towards development of a dangerous blood cancer known as hronic myelogenous leukemia, or CML.

Inflammation is an aspect of the immune response to injury and disease; atherosclerosis, with its characteristic lesions in the blood vessel walls, underlies most cardiovascular disease, including heart attacks and strokes.

Scientists at The Wistar Institute pursuing a promising new immune-system target for anti-atherosclerosis therapies discovered an unwanted potential side effect of any such therapies is a dangerous blood cancer called chronic myelogenous leukemia, or CML. More positively, the CML seen in the genetic strain of mice used in the study closely mimics human CML, so that the mice offer a new model for studying CML, opening the door for researchers to better understand that disease. The Wistar team's results are featured on the cover of the current issue of the Journal of Experimental Medicine, published October 30.

The Wistar scientists initiated their experiments to build on a series of findings that had suggested that blocking certain enzymes called lipoxygenases could inhibit the kind of chronic inflammation in the blood vessel walls that drives the atherosclerotic process. Even better, blocking these enzymes seemed only to affect one type of immune cell, the macrophage, and to interfere only with its role in chronic inflammation. The acute response of the macrophages to infectious agents like bacteria, critical for protection against disease, remained unfettered.

"We and others had hoped that blocking this enzyme would safely slow or stop certain chronic inflammatory responses that have been linked to atherosclerosis," says Ellen Puré, Ph.D., a professor in the Molecular and Cellular Oncogenesis and Immu
'"/>




Page: 1 2 3

Related medicine news :

1. Increase Cereal Fibre To Combat Atherosclerosis
2. Link Established Between Atherosclerosis and Air Pollution
3. Vegetarian Diet Prevents the Development of Atherosclerosis
4. Atherosclerosis and its Mechanics
5. Mothers Healthy Diet Protects Baby from Developing Atherosclerosis
6. Reducing the Risk of Protease Inhibitor-Related Atherosclerosis
7. Early Onset of Atherosclerosis Reported in Obese Children
8. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
9. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
10. Preventive Therapies Found to be More Effective in Managing Migraines
11. Ayurvedic Therapies Cashing In On Medical Tourism
Post Your Comments:
(Date:3/16/2010)... GREENBELT, Md. , March 16 The following is being issued by LibertyProtection.net: , ... ... ... ... On Thursday, March 18 , lawyers from the ...
(Date:3/16/2010)... Larry Minnix, President & CEO, American Association of Homes and Services for the Aging: , ... , ... ... ... "We commend the leadership in Congress and the Administration for their commitment to passing health reform ...
(Date:3/16/2010)... factor for cardiovascular disease and heart failure. But, a ... Rochester Medical Center found that being skinny confers no ... suddenly from cardiac causes. , Scientists found that non-obese ... patients had a 76 percent increase in risk ... patients. Normal and underweight patients showed a startling 99 ...
(Date:3/16/2010)... Reflecting the changing economic landscape, more older workers are staying in the work force, but increasingly in part-time rather than full-time jobs, ... ... , ... ... ...
(Date:3/16/2010)... 2010: Scientists at the University of Liverpool argue ... for health and wellbeing because they tackle the ... psychological causes of overconsumption and weight gain. , ... at the University of Liverpool, points out that ... as their end goal, and do not take ...
Breaking Medicine News(10 mins):Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 2Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 3Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 4Health News:Statement From Larry Minnix, President & CEO, American Association of Homes and Services for the Aging, on the Beginning of the Reconciliation Process for Health Reform Legislation 2Health News:Statement From Larry Minnix, President & CEO, American Association of Homes and Services for the Aging, on the Beginning of the Reconciliation Process for Health Reform Legislation 3Health News:As girth grows, risk of sudden cardiac death shrinks 2Health News:As girth grows, risk of sudden cardiac death shrinks 3Health News:New Research from EBRI: Older Workers Trending Toward More Part-Time Work 2Health News:New Research from EBRI: Older Workers Trending Toward More Part-Time Work 3Health News:Anti-obesity drugs unlikely to provide lasting benefit according to scientists 2Health News:Anti-obesity drugs unlikely to provide lasting benefit according to scientists 3
... medical students are striking against the government proposed quota ... students said that they are going// to conduct a ... school and college students to participate in the demonstration ... Backward Classes (OBC) quota in educational institutions. The medical ...
... Chicago: An Indian American physician, who is president-elect of the ... lead and work with lawmakers in the US on healthcare ... paid in cases of medical negligence. // ,Shastri ... Illinois Psychiatric Society, will take over as Chicago Medical Society ...
... so far succumbed to the malaria epidemic, which is sweeping ... 335,000 people have been infected with the disease. // ... since the disease struck in the state in the beginning ... has a population of 26 million, is the only northeastern ...
... chronic shortage of general practitioners in Australia could lead to ... to improve the situation, at the earliest. // ,Increase ... sure shot way for long term management of the current ... flooding of the medical market. This however would only be ...
... new camera pill has been implemented by the West Virginia ... diagnose all the problems that affect small intestine if not ... patient swallows a small camera that is encapsulated in a ... takes about 50,000 pictures as it travels through the small ...
... that the chest circumference records are beating all the previous ... that better nutrition was the main reason. // , ... chest circumference of Chinese women has increased by 1 cm ... seen only from early 1990s. ,The bra manufacturers ...
Other Medicine News:Health News:Indian American Doctor Wants Healthcare Reforms 2Health News:Chronic shortage of GPs in Australia, Need for Immediate Intervention 2
(Date:3/16/2010)... CorMatrix Cardiovascular, Inc., a medical ... unique extracellular matrix (ECM) biomaterial devices that ... damaged cardiovascular tissue, announced today that investigators ... School of Medicine, Emory University and ... emulsion of the company,s ECM Technology enhances ...
(Date:3/16/2010)... March 16 AstraZeneca (NYSE: ... a new analysis of the PLATO (A Study ... O utcomes) study which showed there were fewer ... who took the investigational oral antiplatelet ticagrelor (BRILINTA™/BRILIQUE™) ... surgery (coronary artery bypass graft, CABG) compared to ...
(Date:3/16/2010)... its catalogue: , ... , , ... ... Atherosclerosis Or Coronary Artery Disease (CAD) - ... ...
Breaking Medicine Technology:CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 2CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 3CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 4CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 5CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 6New PLATO Sub-Analysis of CABG Patients Presented at ACC 2New PLATO Sub-Analysis of CABG Patients Presented at ACC 3New PLATO Sub-Analysis of CABG Patients Presented at ACC 4New PLATO Sub-Analysis of CABG Patients Presented at ACC 5New PLATO Sub-Analysis of CABG Patients Presented at ACC 6New PLATO Sub-Analysis of CABG Patients Presented at ACC 7Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 2Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 3Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 4Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 5Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 6Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 7Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 8Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 9Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 10Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 11Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 12Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 13Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 14Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 15Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 16Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 17Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 18Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 19Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 20Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 21Filmmaker John Hughes 26apos 3B Recent Untimely Death is a Call for Better Understanding 0Aof Sudden Cardiac Death the Leading Cause of Natural Deat 57200 1Filmmaker John Hughes 26apos 3B Recent Untimely Death is a Call for Better Understanding 0Aof Sudden Cardiac Death the Leading Cause of Natural Deat 57200 2Filmmaker John Hughes 26apos 3B Recent Untimely Death is a Call for Better Understanding 0Aof Sudden Cardiac Death the Leading Cause of Natural Deat 57200 3Filmmaker John Hughes 26apos 3B Recent Untimely Death is a Call for Better Understanding 0Aof Sudden Cardiac Death the Leading Cause of Natural Deat 57200 4Filmmaker John Hughes 26apos 3B Recent Untimely Death is a Call for Better Understanding 0Aof Sudden Cardiac Death the Leading Cause of Natural Deat 57200 5Filmmaker John Hughes 26apos 3B Recent Untimely Death is a Call for Better Understanding 0Aof Sudden Cardiac Death the Leading Cause of Natural Deat 57200 6Milliman Report Addresses the Potential Impact of Height and Weight on Medical Costs 57198 1Milliman Report Addresses the Potential Impact of Height and Weight on Medical Costs 57198 2LodgeNet Interactive to Present at the CL King Best Ideas Conference 57196 1LodgeNet Interactive to Present at the CL King Best Ideas Conference 57196 2LodgeNet Interactive to Present at the CL King Best Ideas Conference 57196 3LodgeNet Interactive to Present at the CL King Best Ideas Conference 57196 4LodgeNet Interactive to Present at the CL King Best Ideas Conference 57196 5
... April 15th at EASL Conference in Barcelona,Spain, ... 2007,/PRNewswire-FirstCall/ - MIGENIX Inc. , a clinical-stage ... new top-line results,confirming the previously announced clinical ... benefit, safety and,tolerability in a Phase II ...
... data at the 42nd annual meeting of the ... KENILWORTH, N.J., April 11, 2007 /PRNewswire-FirstCall/ --,Schering-Plough Corporation ... of chronic hepatitis C virus (HCV),infection with several ... Study of the Liver (EASL) 42nd annual meeting,in ...
Other Medicine Technology:New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 2Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 3Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 4Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 5Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 6Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 7
... Powerful and Flexible Impact And Impact2 ... different volume ranges, our single channel Impact ... demands of any application. Engineered with the ... our multichannel line, these pipettors are equally ...
... The total ergonomic solution and ... pipetting!, Soft, feather touch action and ... and strain, Stress-free tip ejection with ... for easy volume identification, Accepts universal ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... long, lever tip ejector, Color coding for ... for greater performance use Hamilton AdvanTip Low ...
... BD Lancet Device offers the ease and comfort ... 90 percent of users in clinical trials agreed ... to use., ,Six depth settings allow you to ... loading and unloading of lancets, the device also ...
Medicine Products: